Steve Scala
Stock Analyst at TD Cowen
(4.48)
# 1,096
Out of 4,556 analysts
391
Total ratings
62.9%
Success rate
10.5%
Average return
Main Sectors:
Stocks Rated by Steve Scala
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Maintained: Buy | $300 | $255.63 | +17.36% | 1 | Jul 13, 2026 | |
| ZTS Zoetis | Rated: Buy | $150 → $104 | $74.19 | +40.18% | 24 | Jun 30, 2026 | |
| SNY Sanofi | Maintained: Hold | $57 | $43.79 | +30.17% | 25 | Jun 29, 2026 | |
| ELAN Elanco Animal Health | Rated: Buy | $24 → $32 | $25.34 | +26.28% | 17 | Jun 18, 2026 | |
| GSK GSK plc | Maintained: Hold | $70 | $50.76 | +37.90% | 29 | Jun 11, 2026 | |
| NVS Novartis AG | Maintained: Hold | $148 → $180 | $153.08 | +17.59% | 34 | Jun 11, 2026 | |
| PFE Pfizer | Maintained: Hold | $30 | $24.82 | +20.87% | 43 | May 6, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | n/a | $12,702.00 | - | 8 | Apr 30, 2026 | |
| RHHBY Roche Holding AG | Maintained: Hold | $67 | $51.70 | +29.59% | 27 | Apr 23, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,250 | $1,163.01 | +7.48% | 47 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $120 → $137 | $127.47 | +7.48% | 31 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 | $253.30 | +10.54% | 39 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $8 | $7.91 | +1.14% | 4 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $64 → $54 | $60.76 | -11.13% | 29 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $15 | $13.52 | n/a | 4 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16.92 | $6.44 | n/a | 2 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $42 | $58.72 | n/a | 4 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.27 | n/a | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.89 | n/a | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 96.59 → CHF 109.47 | CHF 125.34 | n/a | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $155 | $48.19 | n/a | 3 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 1,054 | kr 324.49 | n/a | 1 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 2,250p → 1,790p | 1,911p | n/a | 2 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 367.00 | CHF 332.40 | n/a | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | €42.10 → €98.00 | €76.84 | n/a | 2 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.33 | n/a | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €68.41 → €75.43 | €136.90 | n/a | 4 | Dec 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $209 | $366.05 | n/a | 2 | Oct 3, 2017 |
Johnson & Johnson
Jul 13, 2026
Maintained: Buy
Price Target: $300
Current: $255.63
Upside: +17.36%
Zoetis
Jun 30, 2026
Rated: Buy
Price Target: $150 → $104
Current: $74.19
Upside: +40.18%
Sanofi
Jun 29, 2026
Maintained: Hold
Price Target: $57
Current: $43.79
Upside: +30.17%
Elanco Animal Health
Jun 18, 2026
Rated: Buy
Price Target: $24 → $32
Current: $25.34
Upside: +26.28%
GSK plc
Jun 11, 2026
Maintained: Hold
Price Target: $70
Current: $50.76
Upside: +37.90%
Novartis AG
Jun 11, 2026
Maintained: Hold
Price Target: $148 → $180
Current: $153.08
Upside: +17.59%
Pfizer
May 6, 2026
Maintained: Hold
Price Target: $30
Current: $24.82
Upside: +20.87%
AstraZeneca PLC
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $12,702.00
Upside: -
Roche Holding AG
Apr 23, 2026
Maintained: Hold
Price Target: $67
Current: $51.70
Upside: +29.59%
Eli Lilly and Company
Apr 2, 2026
Maintained: Buy
Price Target: $1,250
Current: $1,163.01
Upside: +7.48%
Mar 30, 2026
Maintained: Hold
Price Target: $120 → $137
Current: $127.47
Upside: +7.48%
Feb 4, 2026
Maintained: Buy
Price Target: $280
Current: $253.30
Upside: +10.54%
Aug 7, 2025
Maintained: Hold
Price Target: $9 → $8
Current: $7.91
Upside: +1.14%
Jul 31, 2025
Maintained: Hold
Price Target: $64 → $54
Current: $60.76
Upside: -11.13%
Apr 22, 2025
Maintained: Hold
Price Target: $19 → $15
Current: $13.52
Upside: n/a
Feb 21, 2025
Maintained: Hold
Price Target: $16.92
Current: $6.44
Upside: n/a
Dec 24, 2024
Rated: Buy
Price Target: $42
Current: $58.72
Upside: n/a
Nov 18, 2024
Downgraded: Hold
Price Target: n/a
Current: $1.27
Upside: n/a
Nov 18, 2024
Downgraded: Hold
Price Target: n/a
Current: $4.89
Upside: n/a
Nov 11, 2024
Maintained: Hold
Price Target: CHF 96.59 → CHF 109.47
Current: CHF 125.34
Upside: n/a
Apr 30, 2024
Reiterated: Buy
Price Target: $80 → $155
Current: $48.19
Upside: n/a
Mar 11, 2024
Maintained: Buy
Price Target: kr 1,054
Current: kr 324.49
Upside: n/a
Nov 30, 2023
Maintained: Hold
Price Target: 2,250p → 1,790p
Current: 1,911p
Upside: n/a
Nov 14, 2022
Downgraded: Hold
Price Target: CHF 367.00
Current: CHF 332.40
Upside: n/a
Jul 21, 2021
Initiated Coverage: Hold
Price Target: €42.10 → €98.00
Current: €76.84
Upside: n/a
Jun 24, 2021
Maintained: Buy
Price Target: n/a
Current: $4.33
Upside: n/a
Dec 10, 2018
Reiterated: Hold
Price Target: €68.41 → €75.43
Current: €136.90
Upside: n/a
Oct 3, 2017
Reiterated: Buy
Price Target: $209
Current: $366.05
Upside: n/a